Ethosuximide
- Generic Name
- Ethosuximide
- Brand Names
- Zarontin
- Drug Type
- Small Molecule
- Chemical Formula
- C7H11NO2
- CAS Number
- 77-67-8
- Unique Ingredient Identifier
- 5SEH9X1D1D
Overview
An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
Background
An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
Indication
For the treatment of petit mal epilepsy.
Associated Conditions
- Petit Mal Epilepsy
Clinical Trials
FDA Approved Products
Ethosuximide
Manufacturer:Epic Pharma, LLC
Route:ORAL
Strength:250 mg in 1 1
Approved: 2020/04/15
NDC:42806-711
Zarontin
Manufacturer:Parke-Davis Div of Pfizer Inc
Route:ORAL
Strength:250 mg in 5 mL
Approved: 2023/06/09
NDC:0071-2418
Ethosuximide
Manufacturer:Bionpharma Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2023/12/27
NDC:69452-152
Ethosuximide
Manufacturer:Greenstone LLC
Route:ORAL
Strength:250 mg in 1 1
Approved: 2021/11/09
NDC:59762-2250
ETHOSUXIMIDE
Manufacturer:Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2020/03/16
NDC:23155-532
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath